A reader pointed me to a recentEconomistarticle on personal genomics. There are numerous tidbits of interest, such as a passing comment about the chaotic Chinese personal genomics industry (about which I know almost nothing). Perhaps the most important quote comes in the closing paragraph:
The ruthless competition in sequencing technology mean that companies in the sequencing industry will spend the next few years butting up against the bottom line, struggling to cut the price of a genome by a few more dollars to match their competitors. That's a tough way to make a living. On the other hand, companies with skills in interpreting genomes - like, say, 23andMe and deCODEme - will be in a good position to take advantage of plummeting sequencing costs to provide useful genetic information to consumers.
And as Church notes, there will also be plenty of room for entrepreneurial individuals with a little programming skill to build their own targeted genome apps - once everyone has their sequence on file there will be plenty of potential customers.
Subscribe to Genetic Future.